Kyowa Kirin constructs drug manufacturing facility in Japan [Yahoo! Finance]
KIRIN HLDGS CO LTD S/ADR (KNBWY)
US:NASDAQ Investor Relations:
kirinholdings.co.jp/english/ir
Company Research
Source: Yahoo! Finance
Investment in the HB7 building totals Y16.8bn ($117m), reflecting the functions of the building in manufacturing, research of biopharmaceutical DS, and staff training. The facility leverages the company's protein engineering and antibody technology. Kyowa Kirin's HB7 building comprises a good manufacturing practices-compliant facility for early-phase investigational drug development and a pilot plant for process development. The facilities leverage single-use technology to minimise cross-contamination risks, potentially accelerating the development and early supply of investigational drugs. The building includes an area for potential future expansion for new manufacturing technologies such as continuous production, along with digitisation and automation, aligning with the company's vision of a smart factory. A training facility for biopharmaceuticals' manufacturing and quality control features equipment enabling trainees to carry out similar simulations of the company's man
Show less
Read more
Impact Snapshot
Event Time:
KNBWY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KNBWY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KNBWY alerts
High impacting KIRIN HLDGS CO LTD S/ADR news events
Weekly update
A roundup of the hottest topics
KNBWY
News
- Orchard Therapeutics Celebrates Addition of Metachromatic Leukodystrophy to the U.S. Recommended Uniform Screening Panel [Yahoo! Finance]Yahoo! Finance
- Kyowa Kirin (TSE:4151) Valuation Check as Shares Climb 11% Year to Date [Yahoo! Finance]Yahoo! Finance
- Kirin (OTCMKTS:KNBWY) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=KNBWY&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a>MarketBeat
- "Ethyl Alcohol and Chemicals Market Size to Hit $1.51 Trillion in 2025" [Yahoo! Finance]Yahoo! Finance
- Kyowa Kirin Announces Proposed Appointment of Abdul Mullick to President and Chief Executive Officer, While Former CEO Masashi Miyamoto to Remain Chairman [Yahoo! Finance]Yahoo! Finance